XML 56 R37.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Inventories, Net (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Inventory Disclosure [Abstract] |
Schedule of Inventory, Current | The Company's net inventories consisted of the following as of December 31:
|  | 2024 |  | 2023
Raw materials |  | $ | 11,982,045 |  |  | $ | 12,619,092 |
Consigned inventory |  | 126,090 |  |  | 149,701 |
Finished goods, net of reserve |  | 2,897,359 |  |  | 4,645,098 |
Total inventories |  | 15,005,494 |  |  | 17,413,891 |
less non-current inventories |  | (11,005,499) |  |  | (12,804,529) |
Total inventories classified as current |  | $ | 3,999,995 |  |  | $ | 4,609,362 |
Schedule of Inventory, Noncurrent | The Company's non-current inventories consisted of the following as of December 31:
|  | 2024 |  | 2023
Vibativ Raw Materials |  | $ | 6,180,347 |  |  | $ | 6,611,426 |
Vibativ Finished Goods |  | 183,057 |  |  | 810,454 |
Kristalose Raw Materials |  | 2,672,720 |  |  | 3,263,515 |
Vaprisol Raw Materials |  | 1,172,849 |  |  | 1,170,641 |
Caldolor Finished Goods |  | 77,382 |  |  | 67,307 |
Sancuso Raw Materials |  | 458,684 |  |  | 574,502 |
Acetadote Raw Materials |  | 23,915 |  |  | — |
Omeclamox |  | 69,622 |  |  | — |
Study Drug Raw Materials |  | 166,923 |  |  | 203,383 |
Other Products |  | — |  |  | 103,300 |
Total non-current inventory |  | $ | 11,005,499 |  |  | $ | 12,804,529 |

X
- References No definition available. + Details
Name: | us-gaap_InventoryDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(c)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1 + Details
Name: | us-gaap_ScheduleOfInventoryCurrentTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle including inventoried costs relating to long-term contracts or programs. + References No definition available. + Details
Name: | us-gaap_ScheduleOfInventoryNoncurrentTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration